Why the study?
Hypertriglyceridemia is a causal risk factor for atherosclerosis, but data regarding dietary interventions on postprandial triglyceride metabolism in mildly to moderately hypertriglyceridemic patients are sparse.
Do meals containing medium-chain fatty acids prevent postprandial hypertriglyceridemia compared to saturated or mono-unsaturated fatty acids in mildly hypertriglyceridemic patients and normolipidemic controls?
Do meals containing medium-chain fatty acids prevent postprandial hypertriglyceridemia compared to saturated or mono-unsaturated fatty acids in mildly hypertriglyceridemic patients and normolipidemic controls?
Replacing saturated fatty acids with medium-chain fatty acids prevents postprandial hypertriglyceridemia in mildly to moderately hypertriglyceridemic patients.
Answers are grounded in this paper and cite their sources.
MCFA meals may blunt postprandial TG rises in mild hypertriglyceridemia; extends limited RCT data but requires larger trials before practice change.
Fasting and postprandial hypertriglyceridemia are causal risk factors for atherosclerosis. The prevalence of hypertriglyceridemia is approximately 25–30% and most hypertriglyceridemic patients suffer from mild to moderate hypertriglyceridemia. Data regarding dietary interventions on postprandial triglyceride metabolism of mildly to moderately hypertriglyceridemic patients is, however, sparse. In a randomized controlled trial, eight mildly hypertriglyceridemic patients and five healthy, normolipidemic controls received three separate standardized fat-meals containing either saturated fatty acids (SFA), mono-unsaturated fatty acids (MUFA), or medium-chain fatty acids (MCFA) in a randomized order. Fasting and postprandial lipid parameters were determined over a 10 h period and the (incremental) area under the curve (AUC/iAUC) for plasma triglycerides and other parameters were determined. MCFA do not lead to a significant elevation of postprandial total plasma triglycerides and other triglyceride parameters, while both SFA (patients: p = 0.003, controls: p = 0.03 compared to MCFA) and MUFA (patients: p = 0.001; controls: p = 0.14 compared to MCFA) do lead to such an increase. Patients experienced a significantly more pronounced increase of plasma triglycerides than controls (SFA: patients iAUC = 1006 mg*h/dL, controls iAUC = 247 mg*h/dL, p = 0.02; MUFA: patients iAUC = 962 mg*h/dL, controls iAUC = 248 mg*h/dL, p = 0.05). Replacing SFA with MCFA may be a treatment option for mildly to moderately hypertriglyceridemic patients as it prevents postprandial hypertriglyceridemia.
No takes yet. Share an insight, caveat, or question.
Folwaczny et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: